Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Toronto Metropolitan University

$359,315.00

A novel approach to treating hemorrhage with mesoporous bioactive glasses.

FY 2015-16

Summary
Hemorrhage is the most common cause of mortality during both surgery and trauma. Mesoporous bioactive glasses (MBGs) have the potential to act as hemostatic agents as their high specific surface area can accelerate blood clotting when applied to a wound. We will build on our preliminary work in this space by synthesizing a range of anti-bacterial, anti-inflammatory MBGs and incorporating them into cellulose gauze. These materials could decrease hemorrhage deaths and become an invaluable tool in both the surgical field and on-board first responder vehicles.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
346589
Name
Towler Mark R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
A novel approach to treating hemorrhage with mesoporous bioactive glasses.
Programtype2
Operating Grants
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$359,315
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bioactivity; Hemorrhage; Mesoporous Glass
Abstract
Hemorrhage is the most common cause of mortality during both surgery and trauma. Mesoporous bioactive glasses (MBGs) have the potential to act as hemostatic agents as their high specific surface area can accelerate blood clotting when applied to a wound. We will build on our preliminary work in this space by synthesizing a range of anti-bacterial, anti-inflammatory MBGs and incorporating them into cellulose gauze. These materials could decrease hemorrhage deaths and become an invaluable tool in both the surgical field and on-board first responder vehicles.
Competitiondate
201603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Towler, Mark R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $359,315~ $0~